Skip to main
DNTH
DNTH logo

Magenta Therapeutics Inc (DNTH)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy DNTH Stock

About Magenta Therapeutics Inc (DNTH)

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
Market cap$667M
Yesterday's volume235.85K
Revenue (TTM)$6.52M
Avg. daily volume300.16K
EBITDA (TTM)-$116.76M
Open$20.70
Price / earnings ratio-7.19x
Yesterday's range$20.1 - $21.05
Debt / equity0.42x
52 week range$13.37 - $32.27
5 year debt / equity0.21x
Beta (LTM)1.22x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio15.99x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

DNTH Stock Rating

What analysts recommend for DNTH stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 22, 2025, the market cap for DNTH stock is $666.99M

The current P/E ratio for DNTH stock is -7.19

The 52-week high for DNTH stock is $32.27. The current DNTH stock price $undefined is 100.00% below its 52-week high

The 52-week low for DNTH stock is $13.37. The current DNTH stock price $undefined has increased 100.00% from its 52-week low

No, the DNTH stock does not pay dividends to its shareholders

The target price for DNTH stock is $50.12 based on the average of what a group of analyst think DNTH stock could be worth at a future date. This is not a prediction by Public.com

How to buy DNTH stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in DNTH stock

    Navigate to the Explore page. Then, type DNTH into the search bar. When you see DNTH stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased DNTH stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Magenta Therapeutics Inc Stock Earnings

The value each DNTH share was expected to gain vs. the value that each DNTH share actually gained.

DNTH (DNTH) reported Q1 2025 earnings per share (EPS) of -$0.82, missing estimates of -$0.71 by 15.49%. In the same quarter last year, DNTH's earnings per share (EPS) was -$0.54. DNTH is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of -$0.88.

Buy DNTH Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.